🌍·6h agodiscovery
Target trial emulation using French MS registry data replicated RCT treatment effects on relapse rate and EDSS progression, but not consistently on MRI outcomes, in patients with multiple sclerosis initiating disease-modifying therapies
Publisher
V
Vera Health
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Vera Health
- Region
- Global
- Scope
- discovery
- Published
- June 29, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: Vera Health
Scope: discovery
Related coverage
More related coverage
openFDA Drug Labels/-597m ago
Drug label update: Loperamide Hydrochloride
Official structured record identifier: 52e6ecc5-5f3d-9989-e063-6294a90af2dc.
openFDA Drug Labels/-597m ago
Drug label update: NYSTATIN
Official structured record identifier: 50737729-a4a4-e747-e063-6394a90adcc5.
Investing.com Canada/2h ago
Dianthus launches phase 3 trial for myasthenia gravis treatment By Investing.com
Endpoints News/2h ago